Earnings

The defence supplier Vincorion has clawed back above its €17 IPO price after a rocky start, but the real test...

Take-Two Interactive: Consumer Confidence Craters as GTA VI Hype Intensifies

A curious disconnect is playing out in the gaming sector. The US video game industry is posting double-digit growth, yet...

Microsoft’s Cloud Growth Faces a Double Threat: A £2.1 Billion Lawsuit and OpenAI’s Spending Pivot

Microsoft enters a pivotal week with its fiscal third-quarter earnings report on Wednesday, but the software giant is navigating a...

Micron’s Political Gambit and Production Crunch: Inside the 424-Euro Rally

The memory-chip maker Micron Technology has become a study in contrasts. Its shares hit a fresh 52-week high of 424.00...

ServiceNow’s $2 Billion Buyback Couldn’t Stop the Bleeding — But Bargain Hunters Are Circling

The math doesn't add up — and that's precisely why ServiceNow investors are confused. The software company delivered a first-quarter...

BioNTech’s Insider Sale Doesn’t Deter Wall Street as Oncology Pipeline Takes Center Stage

The German biotech has clawed back more than 22 percent from its March nadir of €72.50, closing Friday at €88.75....

Apple’s China Comeback and CEO Succession Set the Stage for a Pivotal Earnings Report

Wall Street is bracing for a defining moment at Apple, where a leadership transition and a resurgent Chinese market are...

The Trade Desk’s $750 Million War Chest and a CEO’s $150 Million Conviction Play

Investors scanning The Trade Desk's recent moves see a company placing two very different bets at once. One is a...

Eli Lilly’s Foundayo Stumbles Out of the Gate, Putting Pressure on Upcoming Earnings

Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday, closing at €750....

ImmunityBio’s Record Revenue Overshadowed by FDA Fallout and Cash Burn